Single monthly bacillus Calmette-Guérin intravesical instillation is effective maintenance therapy to prevent recurrence in Japanese patients with non-muscle-invasive bladder cancer

International Journal of Clinical Oncology

Volumn 17, Issue 5, 2012, Pages 477-481

  Okamura, Takehiko ^a   Akita, Hidetoshi ^a   Ando, Ryosuke ^a   Ikegami, Yosuke ^b   Naiki, Taku ^b   Kawai, Noriyasu ^b   Tozawa, Keiichi ^b   Kohri, Kenjiro ^b  

^a ANJO KOSEI HOSPITAL   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Bacillus Calmette Gu rin; Intravesical instillation; Maintenance therapy; Non muscleinvasive bladder cancer

Indexed keywords

BCG VACCINE;

ADULT; AGED; ARTHRITIS; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DRUG FEVER; FEMALE; FOLLOW UP; HEMATURIA; HUMAN; JAPANESE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; NON MUSCLE INVASIVE BLADDER CANCER; PAIN; PRIMARY PREVENTION; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SIDE EFFECT; SURVIVAL RATE; SURVIVAL TIME; TRANSURETHRAL RESECTION; TREATMENT DURATION; TUBERCULOSIS; URINARY FREQUENCY;

ADMINISTRATION, INTRAVESICAL; ADULT; AGED; AGED, 80 AND OVER; BCG VACCINE; CANCER VACCINES; CARCINOMA, TRANSITIONAL CELL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84869496502     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-011-0314-3     Document Type: Article

References (14)

1. Sylvester RJ, van der Meijden AP, Lamm DL (2002) Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol 168:1964-1970
2. Sarosdy MF, Lamm DL (1989) Long-term results of intravesical bacillus Calmette-Guérin therapy for superficial bladder cancer. J Urol 142:719-722
3. Cookson MS, Sarosdy MF (1992) Management of stage T1 superficial bladder cancer with intravesical bacillus Calmette- Guérin therapy. J Urol 148:797-801
4. Margel D, Tal R, Golan S et al (2007) Long-term follow-up of patients with stage T1 high grade transitional cell carcinoma managed by bacillus Calmette-Guérin immunotherapy. Urology 69:78-82
5. Okamura T, Tozawa K, Yamada Y et al (1996) Clinicopathological evaluation of repeated courses of intravesical bacillus Calmette-Guérin instillation for preventing the recurrence of initially resistant superficial bladder cancers. J Urol 156:967-969
6. Gårdmark T, Jahnson S, Wahlquist R et al (2007) Analysis of progression and survival after 10 years of a randomized prospective study comparing mitomycin-C and bacillus Calmette- Guérin in patients with high-risk bladder cancer. BJU Int 99:817-820
7. Lamm DL, Blumenstein BA, Crissman JD et al (2000) Maintenance bacillus Calmette-Guérin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder cancer: a randomized Southwest Oncology Group Study. J Urol 163:1124-1129
8. Badalament RA, Herr HW, Won GY et al (1987) A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guerin therapy of superficial bladder cancer. J Clin Oncol 5:441-449
9. Bedeir AED, Sarhan O, Nabeeh A et al (2007) Maintenance intravesical BCG therapy for superficial bladder tumours: 3 week multiple courses versus monthly doses. J Urol 177(4):522 (Abstract 1579)
10. Koga H, Ozono S, Tsushima T et al (2010) Maintenance intravesical bacillus Calmette-Guerin instillation for Ta, T1 cancer and carcinoma in situ of the bladder: randomized controlled trial by the BCG Tokyo Strain Study Group. Int J Urol 17:759-767
11. Hinotsu S, Akaza H, Naito S et al (2011) Maintenance therapy with bacillus Calmette-Guérin Connaught strain clearly prolongs recurrence-free survival following transurethral resection of bladder tumour for non-muscle-invasive bladder cancer. BJU Int 107:1-9
12. -(2001) 3rd edition of the General rules for clinical and pathological studies on bladder cancer of the Japanese Urological Association and the Japanese Society of Pathology. Kanehara & Co., Ltd, Tokyo
13. Okamura T, Akita H, Hashimoto Y et al (2010) Non muscle invasive bladder cancer cases initially failing to respond to bacillus Calmette-Guérin intravesical instillation therapy. Curr Urol 4:18-24
14. Herr HW (2008) Is maintenance bacillus Calmette-Guérin really necessary? Eur Urol 54:971-973